Treatment and vision-related quality of life in the early manifest glaucoma trial.
about
Laser trabeculoplasty for open angle glaucomaMedical interventions for primary open angle glaucoma and ocular hypertensionQuality of Life in Glaucoma: A Review of the LiteratureEvaluation of various machine learning methods to predict vision-related quality of life from visual field data and visual acuity in patients with glaucoma.The effect of different criteria on the number of patients blind from open-angle glaucomaIntravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life.Linguistic and psychometric validation of the Chinese version of the Glaucoma Quality of Life-15 (GQL-15-CHI): a cross-sectional studyIdentifying areas of the visual field important for quality of life in patients with glaucoma.Use of patient-reported outcomes in medical product development: a report from the 2009 NEI/FDA Clinical Trial Endpoints Symposium.Contrasting the use of 2 vision-specific quality of life questionnaires in subjects with open-angle glaucoma.Comparison of visual performance of multifocal intraocular lenses with same material monofocal intraocular lenses.Ophthalmic and Glaucoma Treatment Characteristics Associated With Changes in Health-related Quality of Life Before and After Newly Diagnosed Primary Open-angle Glaucoma in Nurses' Health Study Participants.A prospective, longitudinal, observational cohort study examining how glaucoma affects quality of life and visually-related function over 4 years: design and methodologyQuality of life and visual acuity outcomes in the Registry in Glaucoma Outcomes Research study.Practical recommendations for measuring rates of visual field change in glaucoma.Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up.Health-related quality of life following blind rehabilitationThe quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degenerationImpact of better and worse eye damage on quality of life in advanced glaucoma.Choosing appropriate patient-reported outcomes instrument for glaucoma research: a systematic review of vision instruments.Predictive factors for comorbid psychiatric disorders and their impact on vision-related quality of life in patients with high myopia.Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma.Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma.Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice.The rising cost of glaucoma drugs.The times they are a-changin': time to change glaucoma management.Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol.Comparison of vision-related quality of life in primary open-angle glaucoma and dry-type age-related macular degeneration.Perceived vision-related quality of life and risk of falling among community living elderly people.Predicting Visual Disability in Glaucoma With Combinations of Vision Measures.Modified Bahasa Malaysia version of VF-14 questionnaire: assessing the impact of glaucoma in rural area of Malaysia.Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment.Comparison of visual performance of toric versus non-toric intraocular lenses with same material
P2860
Q24242939-0265D8AB-59CA-4390-890F-EC32C153A0CCQ24243220-570F6EE3-1AC5-4AF3-B14E-54A65A6B9B17Q26747891-1AACD35A-EE9D-4A41-9037-6443CAA615BEQ30814168-A2999670-14F6-4158-83F3-40A4D1ED1CD9Q34072142-8785DF26-669D-4A7B-8CF4-E3DB7D12C802Q34160687-9624CB43-CD01-42AA-A1A9-74C569100C68Q34493340-7077D74A-836F-4342-A457-08C2051DEFE0Q34631891-864C0C96-6EB0-434A-9241-61410CB3A22FQ34662096-E2C9A048-88BE-48A5-B86F-D77F81909B5BQ34692207-746F4282-4546-463B-9A01-A66C78025A29Q34808661-0AE5A4ED-1936-4BF0-A6B3-2EDACD22E471Q35678771-C21BF561-96A4-42F3-A424-8BC8CC5B473EQ35731894-E76F5138-C8B5-4C1E-A96A-BDC96B342C0CQ35874757-49069540-1841-41E2-936B-8BD0FB6BBDA2Q37062593-FD1C7068-405F-4755-B53D-5CB87B8794B9Q37238332-0CDD9317-364C-4D49-9E88-CE4FC84F70F6Q37248636-C7A4D5A4-D3C5-45D1-AE1D-9375EBA6E8D0Q37297814-B459D6A8-9A4A-42F0-9630-D60D021F4DD2Q37736574-54516C42-964C-46B9-92FC-7A3DC1D77884Q37825805-2B0251A9-9AB5-49BF-97C9-BB82B7A2B1CDQ38548245-19E31B1C-E0AF-4C73-824E-0B5AEC509796Q38679205-E5661CDC-11F5-4A6C-9817-82035785549CQ38988955-93D8410D-FC66-406A-9D23-44E2E0580701Q40967974-7031E2D3-54A5-4931-810E-66CC0A9C7B7FQ41183306-278AE204-54EC-48DF-9BD4-E720DFA8454FQ42835925-452E84F1-186A-4777-8C4E-E614A655424DQ43544157-38E9A494-775B-4493-9726-31781599AE2AQ47232823-90867253-61CE-4CC3-9E29-3786738F92FAQ47626169-076C2757-9ED9-4DB5-870E-F960D66ABA76Q48246098-F99AC0C8-D4CE-47D4-ACC6-61736E0D7047Q52578982-919BFE4F-4EFD-473E-B390-A637C80570C8Q53150577-C14F6E71-8991-4EA4-8839-8DD4D6010743Q55056029-44BECC70-450E-4FD4-9BD2-8CE212AD799DQ59135183-9BA5902B-69F1-467E-AA2E-63416D845A5E
P2860
Treatment and vision-related quality of life in the early manifest glaucoma trial.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Treatment and vision-related quality of life in the early manifest glaucoma trial.
@ast
Treatment and vision-related quality of life in the early manifest glaucoma trial.
@en
type
label
Treatment and vision-related quality of life in the early manifest glaucoma trial.
@ast
Treatment and vision-related quality of life in the early manifest glaucoma trial.
@en
prefLabel
Treatment and vision-related quality of life in the early manifest glaucoma trial.
@ast
Treatment and vision-related quality of life in the early manifest glaucoma trial.
@en
P2093
P1433
P1476
Treatment and vision-related quality of life in the early manifest glaucoma trial.
@en
P2093
Anders Heijl
Bo Bengtsson
Early Manifest Glaucoma Trial Group
Eugene Komaroff
Leslie G Hyman
M Cristina Leske
P304
P356
10.1016/J.OPHTHA.2005.03.028
P577
2005-09-01T00:00:00Z